Barrington Research analyst Vincent Colicchio maintains Outfront Media (NYSE:OUT) with a Outperform and lowers the price target from $33 to $27.
The Rising Challenge for Intercept Pharmaceuticals: Analyst Downgrade Amid Ocaliva’s DILI Concerns
Canaccord Genuity has lowered the price target for Intercept Pharmaceutical Inc (NASDAQ: ICPT) from $26 to $12,